Compounds > levodopa
Page last updated: 2024-08-17

levodopa and cyclohexanol

levodopa has been researched along with cyclohexanol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bari, M; Battista, N; Bernardi, G; Calabresi, P; Centonze, D; Finazzi-Agrò, A; Gubellini, P; Maccarrone, M; Picconi, B1
Corbeil, P; McDonald, J; Pourcher, E1
Ardashov, OV; Il'ina, IV; Karpova, EV; Korchagina, DV; Morozova, EA; Pavlova, AV; Salakhutdinov, NF; Tolstikova, TG; Volcho, KP1
Ansari, S; Barawkar, DA; Basu, S; Bhamidipati, RK; Bhat, G; Chaudhary, S; Chug, A; De, S; Ghosh, I; Jain, V; Menon, S; Meru, AV; Mookhtiar, KA; Naykodi, M; Palle, VP; Patel, M; Patil, H; Prasad, V; Quraishi, A; Rouduri, SR; Salve, Y; Seervi, MS; Shejul, YD; Thakare, R; Thorat, S; Unadkat, V1

Other Studies

4 other study(ies) available for levodopa and cyclohexanol

ArticleYear
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism.
    Journal of neurochemistry, 2003, Volume: 85, Issue:4

    Topics: Amidohydrolases; Animals; Antiparkinson Agents; Arachidonic Acids; Binding, Competitive; Cannabinoid Receptor Modulators; Cerebellum; Corpus Striatum; Cyclohexanols; Disease Models, Animal; Endocannabinoids; Excitatory Postsynaptic Potentials; Fatty Acids, Unsaturated; Glutamic Acid; Glycerides; In Vitro Techniques; Levodopa; Oxidopamine; Parkinsonian Disorders; Patch-Clamp Techniques; Phospholipase D; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug

2003
Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.
    The American journal of geriatric pharmacotherapy, 2011, Volume: 9, Issue:2

    Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cyclohexanols; Dementia, Vascular; Diagnosis, Computer-Assisted; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Microvessels; Paroxetine; Postural Balance; Venlafaxine Hydrochloride

2011
Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.
    Journal of medicinal chemistry, 2011, Jun-09, Volume: 54, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Cyclohexanols; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Haloperidol; Levodopa; Mice; Mice, Inbred C57BL; Molecular Conformation; Motor Activity; Neurotoxins; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Neurotransmitter; Stereoisomerism

2011
Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A
    Journal of medicinal chemistry, 2017, 01-26, Volume: 60, Issue:2

    Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Benzothiazoles; Cyclohexanols; Drug Design; HEK293 Cells; Humans; Levodopa; Male; Microsomes, Liver; Molecular Docking Simulation; Rats, Wistar; Receptor, Adenosine A2A; Structure-Activity Relationship

2017